World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
45257
World Ranking
9129
National Ranking
4708

Dan G. Duda publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dan G. Duda sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 411 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dan G. Duda D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dan G. Duda sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dan G. Duda is affiliated with Harvard University in the United States and has an extensive research record primarily in medicine and biochemistry, genetics, and molecular biology.

The main fields of study in their work include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their research encompasses several subfields, notably:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Cancer Research
  • Immunology

Major topics covered in their research are as follows:

  • Cancer Immunotherapy and Biomarkers
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pancreatic and Hepatic Oncology Research
  • Cancer Mechanisms and Therapy
  • Cancer Genomics and Diagnostics
  • Cancer, Hypoxia, and Metabolism
  • Ferroptosis and cancer prognosis

Recent papers authored or co-authored by Dan G. Duda include:

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC, 2021, published in Nature
  • The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma, 2020, published in JAMA Oncology
  • Fatty acid synthesis is required for breast cancer brain metastasis, 2021, published in Nature Cancer
  • Combining microenvironment normalization strategies to improve cancer immunotherapy, 2020, published in Proceedings of the National Academy of Sciences
  • Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy, 2022, published in Nature Communications

The scientist frequently publishes in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Cancers

Frequent collaborators include:

  • Rakesh K. Jain
  • Peigen Huang
  • Dai Fukumura
  • Ahmed O. Kaseb
  • Zohreh Amoozgar

Best Publications

  • Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    Christopher G Willett;Yves Boucher;Emmanuelle di Tomaso;Dan G Duda

  • AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

    Tracy T. Batchelor;A. Gregory Sorensen;A. Gregory Sorensen;Emmanuelle di Tomaso;Wei Ting Zhang;Wei Ting Zhang

  • NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES

    Shom Goel;Dan G. Duda;Lei Xu;Lance L. Munn

  • Angiogenesis in brain tumours

    Rakesh K. Jain;Emmanuelle di Tomaso;Dan G. Duda;Jay S. Loeffler

  • Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

    Dai Fukumura;Jonas Kloepper;Zohreh Amoozgar;Dan G. Duda

  • Lessons from phase III clinical trials on anti-VEGF therapy for cancer

    Rakesh K Jain;Dan G Duda;Jeffrey W Clark;Jay S Loeffler

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Pfister;Dominik Pfister;Nicolás Gonzalo Núñez;Roser Pinyol;Olivier Govaere

  • Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

    Yuhui Huang;Jianping Yuan;Elda Righi;Walid S. Kamoun

  • Engineering vascularized tissue

    Rakesh K Jain;Patrick Au;Josh Tam;Dan G Duda

  • Differentiating the pathologies of cerebral malaria by postmortem parasite counts.

    Terrie E Taylor;Wenjiang J Fu;Wenjiang J Fu;Richard A Carr;Richard O Whitten

  • Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

    Apinya Jusakul;Apinya Jusakul;Ioana Cutcutache;Chern Han Yong;Jing Quan Lim

  • Biomarkers of response and resistance to antiangiogenic therapy.

    Rakesh K. Jain;Dan G. Duda;Christopher G. Willett;Dushyant V. Sahani

  • Vascular normalization as an emerging strategy to enhance cancer immunotherapy.

    Yuhui Huang;Shom Goel;Dan G. Duda;Dai Fukumura

  • Malignant cells facilitate lung metastasis by bringing their own soil

    Dan G. Duda;Annique M. M. J. Duyverman;Mitsutomo Kohno;Matija Snuderl

  • HCC and angiogenesis: possible targets and future directions

    Andrew X. Zhu;Dan G. Duda;Dushyant V. Sahani;Rakesh K. Jain

  • Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

    Christopher G. Willett;Dan G. Duda;Emmanuelle di Tomaso;Yves Boucher

  • Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

    Rakesh R. Ramjiawan;Arjan W. Griffioen;Dan G. Duda

  • Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

    Tracy T. Batchelor;Dan G. Duda;Emmanuelle di Tomaso;Marek Ancukiewicz

  • Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

    Andrew X. Zhu;Dushyant V. Sahani;Dan G. Duda;Emmanuelle di Tomaso

  • Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo

    Mark Stroh;John P Zimmer;Dan G Duda;Tatyana S Levchenko

Frequent Co-Authors

Rakesh K. Jain
Rakesh K. Jain Harvard University
Dai Fukumura
Dai Fukumura Harvard University
Andrew X. Zhu
Andrew X. Zhu Harvard University
Tracy T. Batchelor
Tracy T. Batchelor Brigham and Women's Hospital
Jeffrey W. Clark
Jeffrey W. Clark Harvard University
Christopher G. Willett
Christopher G. Willett Duke University
Patrick Y. Wen
Patrick Y. Wen Harvard University
Yves Boucher
Yves Boucher Harvard University
Dushyant V. Sahani
Dushyant V. Sahani University of Washington
Lance L. Munn
Lance L. Munn Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens the door to a variety of rewarding healthcare careers. For those seeking alternative pathways or specializing in emerging health fields, online degree programs can offer flexibility and affordability.

For example, pursuing a health information management bachelor degree online can lead to roles managing patient data and healthcare records, an area that's crucial in today's digitized medical environment.

Those interested in supporting healthcare efficiency can explore medical coding certification cost to learn about streamlined certification and entry into medical billing and coding roles—a fast-growing career option.

Nursing continues to be in high demand. Prospective nurses can start their journey via online nursing programs, while experienced nurses may consider specialized online nurse practitioner programs to advance their practice.

These online degrees and certifications offer flexible options to build a career in health care—whether at the bedside, behind the scenes, or in administration.

Best Scientists Citing Dan G. Duda

Trending Scientists